مالطا - الإنجليزية - Medicines Authority

panpharma z.i. du clairay, 35133 luitre, france - thiopental sodium - powder for solution for injection - thiopental sodium 1000 mg - anesthetics

مالطا - الإنجليزية - Medicines Authority

panpharma z.i. du clairay, 35133 luitre, france - dexamethasone - solution for injection - dexamethasone 6.6 mg - corticosteroids for systemic use

مالطا - الإنجليزية - Medicines Authority

panpharma z.i. du clairay, 35133 luitre, france - dexamethasone - solution for injection - dexamethasone 3.3 mg - corticosteroids for systemic use

مالطا - الإنجليزية - Medicines Authority

panpharma z.i. du clairay, 35133 luitre, france - dexamethasone sodium, phosphate - solution for injection - dexamethasone sodium phosphate 6 mg - corticosteroids for systemic use

مالطا - الإنجليزية - Medicines Authority

panpharma z.i. du clairay, 35133 luitre, france - hydrocortisone sodium, succinate - powder for solution for infusion or injection - hydrocortisone sodium succinate 133.7 mg - corticosteroids for systemic use

مالطا - الإنجليزية - Medicines Authority

panpharma z.i. du clairay, 35133 luitre, france - flucloxacillin - powder for solution for infusion or injection - flucloxacillin 500 mg - antibacterials for systemic use

مالطا - الإنجليزية - Medicines Authority

panpharma z.i. du clairay, 35133 luitre, france - flucloxacillin - powder for solution for infusion or injection - flucloxacillin 250 mg - antibacterials for systemic use

مالطا - الإنجليزية - Medicines Authority

panpharma z.i. du clairay, 35133 luitre, france - flucloxacillin - powder for solution for infusion or injection - flucloxacillin 1 g - antibacterials for systemic use

أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

panpharma - gentamicin sulfate - solution for injection/infusion - 40 milligram(s)/millilitre - other aminoglycosides; gentamicin

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

panpharma australia pty ltd - linezolid, quantity: 600 mg - injection, solution - excipient ingredients: glucose monohydrate; sodium citrate dihydrate; citric acid; hydrochloric acid; sodium hydroxide; water for injections - linezolid is indicated for the treatment of suspected or proven infections due to gram positive organisms resistant to multiple classes of antibiotics, including methicillin resistant staphylococcus species and vancomycin resistant enterococcus species. linezolid is active against gram-positive bacteria only. linezolid has no clinical activity against gram-negative pathogens. specific gram-negative therapy is required if a concomitant gram-negative pathogen is documented or suspected.